Structure Therapeutics stock: what's driving sudden 103% jump in GPCR shares?

Structure Therapeutics stock (NASDAQ: GPCR) rocketed above 103% Monday, trading near $70, after the clinical-stage biotech released promising mid-stage results for its oral obesity drug, aleniglipron.... ...